Dialysis & Nephrology Digest - September 2022

Fresenius CEO resigning; to be replaced by head of company’s pharmaceutical business -

Michael Sen, President and CEO of Fresenius Kabi, will replace Stephan Sturm as CEO of Fresenius SE on Oct. 1. Shares in the company fell 44% over the past year, in part due to the COVID pandemic and a surge of costs but Fresenius’ stock price rose by nearly 6% immediately after Sturm’s announcement. The change at the top mirrors the shake up in leadership at Fresenius Medical Care (FMC), where Carla Kriwet will take over as CEO at the world’s largest dialysis provider from Rice Powell on Oct. 1. FMC’s share price reached a 12- year low in July following a 12% plunge.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Benesch

Written by:

Benesch
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Benesch on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide